Harnessing the power of nature and cutting-edge 3D bioprinting technology to create advanced wound healing solutions that accelerate recovery and reduce infection risks.
Bioconvergence-Attic Private Limited is pioneering the development of Moringa leaf nanoparticles for advanced wound healing applications. Moringa leaf is a rich source of bioactive compounds with proven antimicrobial, anti-inflammatory, and antioxidant properties.
Our research focuses on synthesizing nanoparticles using Moringa leaf extracts and incorporating them into innovative wound healing patches. These patches utilize our proprietary bioink formulation that can be 3D bioprinted to create customized wound care solutions.
By combining nature's healing power with advanced biotechnology, we're creating the next generation of wound care that promotes faster healing, reduces infection risks, and minimizes scarring.
Learn MoreWe've developed a proprietary method for synthesizing nanoparticles from Moringa leaf extracts, preserving their bioactive compounds while enhancing bioavailability and therapeutic efficacy.
Our indigenous 3D bioprinter enables precise fabrication of wound healing patches with controlled release of therapeutic compounds, customized to specific wound types and patient needs.
We've created a novel bioink incorporating Moringa nanoparticles that maintains stability during printing while ensuring optimal drug delivery and compatibility with human tissue.
Our patches accelerate healing of chronic wounds, burns, and surgical incisions while significantly reducing infection rates through sustained antimicrobial action.
Our technology enables creation of alternative biomedical models for drug testing, reducing reliance on animal testing while improving predictive accuracy.
Beyond wound healing, our platform supports development of tissue engineering solutions for various medical applications in regenerative medicine.
Bioactive compounds are extracted from Moringa leaves and converted into nanoparticles using our green synthesis approach.
Nanoparticles are incorporated into our proprietary bioink formulation optimized for 3D bioprinting and controlled drug release.
Using our indigenous bioprinter, we fabricate customized wound healing patches with precise architecture and drug distribution.
Patches undergo rigorous testing for efficacy, safety, and performance before being prepared for clinical applications.
We're developing our own 3D bioprinter specifically designed for fabricating biomedical models and wound healing patches. This technology enables us to create complex structures with precise control over material composition and drug distribution.
Our bioprinter represents a significant advancement in the field of regenerative medicine, offering capabilities for drug discovery, drug delivery systems, and tissue engineering while helping reduce animal testing through more accurate in vitro models.
By controlling both the bioprinting technology and the bioink formulation, we can optimize the entire process for maximum therapeutic outcomes and cost-effectiveness.
Partner With UsInterested in our technology or potential collaborations? Reach out to us to learn more about our innovative wound healing solutions.